Right ventricular pacing and heart failure: minimization strategies
Permanent pacing can prevent bradycardia, syncope, and pauses, yet the electrical sequence created by conventional right ventricular stimulation may have adverse long-term effects. When activation begins in the right ventricular apex or septum rather than through the His–Purkinje system, ventricular contraction can become less coordinated. In susceptible patients, this dyssynchrony may contribute to adverse remodeling, declining left ventricular function, atrial arrhythmias, and clinical heart failure.
The central management question is therefore more specific than whether a patient needs a pacemaker. Clinicians must also determine how much ventricular pacing is necessary, which site and conduction system are most suitable, and how the device should be programmed over time. A thoughtful strategy can preserve native conduction when it is reliable while avoiding unnecessary exposure to a high right ventricular pacing burden.
Risk assessment should continue after implantation. Device interrogation, echocardiography, symptoms, electrocardiographic changes, and medication review provide complementary information. Early recognition of a rising pacing percentage or falling ejection fraction creates an opportunity to adjust programming or consider a more physiological pacing approach before heart failure becomes established.
Why ventricular pacing burden matters
Right ventricular pacing can produce a left bundle branch block-like activation pattern, with delayed stimulation of the lateral and basal left ventricle. The resulting mechanical discoordination may increase mitral regurgitation, alter filling, and raise myocardial energy requirements. The effect varies considerably between individuals, so pacing percentage should be interpreted alongside baseline ventricular function, QRS duration, scar burden, valvular disease, and clinical status.
A high cumulative burden is commonly discussed at thresholds around 20% to 40%, although no single percentage applies to every patient. Some patients develop pacing-induced cardiomyopathy with a comparatively modest burden, while others tolerate frequent pacing for years. A wide paced QRS, reduced baseline ejection fraction, male sex, pre-existing conduction disease, and a history of atrial fibrillation may increase vulnerability.
The objective is not to minimize pacing at any cost. A patient with intermittent high-grade atrioventricular block may require dependable ventricular support, and excessive efforts to preserve intrinsic conduction can cause pauses or inadequate rate support. Safety, hemodynamic needs, and the reason for implantation must remain the primary determinants.
Identifying patients who need closer surveillance
Before implantation, echocardiography should establish left ventricular ejection fraction, chamber dimensions, right ventricular function, and relevant valve disease. A 12-lead ECG can document PR interval, QRS width, bundle branch block, and the likelihood that native atrioventricular conduction will remain usable. Ambulatory monitoring is helpful when symptoms and conduction findings do not align.
The indication also predicts future pacing exposure. Sinus node dysfunction often allows periods of intact atrioventricular conduction, making ventricular pacing reduction feasible. Advanced atrioventricular block, slow conducted atrial fibrillation, and extensive infra-Hisian disease generally make minimization less realistic. Patients with an anticipated substantial pacing requirement and a reduced or borderline ejection fraction deserve particular consideration of conduction system pacing or cardiac resynchronization therapy from the outset.
Follow-up should be individualized rather than based solely on a fixed annual visit. Remote monitoring can reveal changes in pacing percentage, atrial arrhythmia duration, ventricular rate, lead performance, and heart failure-related trends. A new decline in exercise capacity, edema, orthopnea, or unexplained fatigue warrants clinical review even when the device appears to function normally.
Programming that preserves native conduction
For patients with intermittent atrioventricular conduction, atrial-based pacing with ventricular backup may substantially reduce right ventricular stimulation. Algorithms such as AAI-to-DDD switching, managed ventricular pacing, and periodic conduction searches allow the device to remain in an atrial-based mode until conduction fails. These functions require careful selection because inappropriate mode changes or long pauses can be hazardous in patients with unreliable conduction.
Adaptive atrioventricular delay is another option. The device periodically lengthens the sensed or paced AV interval to test whether an intrinsic ventricular event will occur. Programming must account for the patient’s PR interval, exertional conduction, symptoms, and risk of pacemaker-mediated arrhythmia. An excessively long AV delay can impair diastolic filling, promote atrial contraction against closed valves, or create symptoms resembling pacemaker syndrome.
Device clinics should document the rationale for the selected mode and the acceptable pacing range. A sudden increase in ventricular pacing may indicate progression of conduction disease, medication effects, atrial arrhythmia, lead problems, or a programming change. Educational resources and focused special issues can help teams keep pace with developments in device therapy, electrophysiology, and heart failure management.
Comparing pacing approaches
The best approach depends on expected pacing dependence, ventricular function, anatomy, operator experience, and the patient’s future rhythm trajectory. Conventional right ventricular pacing remains appropriate for many individuals, particularly when expected burden is low and ventricular function is preserved. Conduction system pacing and resynchronization require greater procedural planning but may reduce electrical dyssynchrony when frequent pacing is unavoidable.
| Approach | Main role | Potential benefit | Important limitations |
|---|---|---|---|
| Conventional right ventricular pacing | Bradycardia with low or moderate anticipated burden | Familiar technique, reliable implantation, broad availability | Dyssynchronous activation and possible pacing-induced cardiomyopathy |
| Atrial-based pacing with ventricular backup | Sinus node dysfunction with reliable AV conduction | Reduces unnecessary ventricular pacing | Unsafe or ineffective with advanced conduction disease |
| His-bundle pacing | Patients in whom near-normal activation is desirable | Uses the native conduction pathway | Higher thresholds, lead revision concerns, and technical complexity |
| Left bundle branch area pacing | Frequent pacing or resynchronization need | Usually provides a narrower paced QRS than conventional RV pacing | Septal anatomy, perforation risk, and evolving long-term evidence |
| Biventricular CRT | Reduced EF with wide QRS or high pacing-related dyssynchrony | Coordinates ventricular contraction and can improve remodeling | More leads, venous challenges, phrenic stimulation, and procedural burden |
These categories are not interchangeable. A patient with a narrow native QRS and normal ejection fraction may need only a pacing-minimization algorithm, whereas someone with anticipated near-continuous pacing and reduced systolic function may benefit from a physiological or resynchronization strategy. Shared decision-making should include the likelihood of future upgrades and the consequences of each approach.
When minimization is no longer enough
A falling ejection fraction accompanied by a high ventricular pacing burden raises concern for pacing-induced cardiomyopathy, particularly after other causes have been evaluated. Ischemia, uncontrolled hypertension, tachycardia-mediated cardiomyopathy, infiltrative disease, valve disease, myocarditis, and poor adherence to guideline-directed medical therapy can produce a similar clinical picture. The diagnosis is strongest when ventricular dysfunction develops after substantial pacing without another convincing explanation.
Initial management may include correcting programming, optimizing heart failure medication, treating atrial tachyarrhythmias, and checking lead integrity. If the patient has a high burden and persistent ventricular dysfunction or heart failure symptoms, an upgrade to cardiac resynchronization therapy or conduction system pacing should be evaluated. The decision should include venous access, existing lead location, infection risk, renal function, frailty, life expectancy, and the feasibility of extracting or abandoning older leads.
Cardiac resynchronization can be particularly relevant when there is reduced ejection fraction, a wide paced QRS, and a strong expectation that frequent ventricular pacing will continue. His-bundle or left bundle branch area pacing may offer an alternative in selected patients, including some who have failed conventional CRT or have anatomy that makes coronary sinus lead placement difficult. The evidence base continues to develop, so procedural expertise and careful follow-up are essential.
Integrating rhythm and heart failure care
A device strategy should be coordinated with rhythm management rather than treated as an isolated technical decision. Atrial fibrillation can increase ventricular pacing, alter mode behavior, and worsen filling or rate control. In patients with persistent arrhythmia and poor biventricular capture, AV node ablation with CRT or conduction system pacing may be considered in appropriate circumstances. Conversely, preserving intrinsic AV conduction may be valuable when it remains stable and produces an effective native ventricular response.
Lead placement and future procedures also benefit from anatomic planning. Electrophysiology teams familiar with challenging anatomy, including the considerations described in CTI anatomy guidance, are well positioned to integrate imaging, prior procedures, venous access, and anticipated revisions into a broader device plan. Although a cavotricuspid isthmus procedure is distinct from pacing, the same attention to anatomy and procedural strategy supports safer complex electrophysiology care.
The most useful endpoint is clinical stability with preserved ventricular function, rather than a particular programming label. Device interrogation should be paired with echocardiographic trends and symptom assessment. A low pacing percentage is desirable only when it is achieved without pauses, poor rate response, worsening AV synchrony, or reduced quality of life.
Practical priorities for clinical teams
A reproducible workflow helps prevent avoidable ventricular pacing while protecting patients who need dependable support:
- Estimate the expected pacing burden before implantation using the indication, ECG, monitoring, and structural assessment.
- Record baseline ejection fraction, native QRS duration, PR interval, symptoms, and relevant valve or myocardial disease.
- Use atrial-based or conduction-preserving algorithms when AV conduction is reliable, with safety limits that prevent clinically important pauses.
- Review pacing percentage, paced QRS duration, arrhythmia burden, lead function, and heart failure symptoms during remote and in-person follow-up.
- Investigate new ventricular dysfunction promptly and consider CRT or conduction system pacing when high-burden pacing is persistent and clinically consequential.
Programming should be revisited after medication changes, new atrial fibrillation, hospitalization, syncope, or an unexpected increase in pacing. A static setting may become inappropriate as conduction disease progresses or activity level changes. Exercise testing, ambulatory monitoring, or an in-office conduction assessment can clarify whether intrinsic conduction is adequate during daily activity.
Heart failure prevention also depends on standard cardiovascular care. Blood pressure control, ischemia evaluation, diabetes management, sleep apnea assessment, physical activity adapted to functional status, and guideline-directed pharmacotherapy may reduce the likelihood that a pacing-related decline is amplified by other myocardial stressors.
The Journal of Arrhythmia offers clinicians and researchers a venue for examining these decisions through original studies, reviews, guidelines, and device-focused educational material. Applying that evidence at the bedside means treating pacing burden as a dynamic clinical variable and matching the pacing method to the patient’s conduction system, ventricular function, and long-term needs. Share this framework within the electrophysiology and heart failure team, incorporate it into device follow-up pathways, and use timely reassessment to keep necessary pacing as physiological as possible.